Management of Acute Gout Flare
For acute gout, initiate treatment immediately with corticosteroids, NSAIDs, or colchicine—with corticosteroids preferred as first-line therapy due to superior safety profile and equivalent efficacy. 1
Immediate Treatment Options (Choose One)
All three first-line agents are equally effective for pain reduction in acute gout 1. Selection depends on patient-specific contraindications:
Corticosteroids (Preferred First-Line)
- Prednisolone 35 mg daily for 5 days 1
- Safest option with fewer adverse effects compared to NSAIDs
- Contraindications: systemic fungal infections
- Monitor for: hyperglycemia, fluid retention (short-term use minimizes risk)
NSAIDs (Alternative First-Line)
- Any NSAID is acceptable—no evidence that indomethacin is superior to naproxen or ibuprofen 1
- Contraindications: renal disease, heart failure, cirrhosis
- Risk: GI bleeding, perforation, ulcers
Colchicine (Alternative First-Line)
- Low-dose regimen: 1.2 mg, then 0.6 mg one hour later, followed by 0.5 mg 2-3 times daily 2
- This low-dose approach is as effective as high-dose but with significantly fewer GI adverse effects 1
- Stop immediately if diarrhea develops (first sign of toxicity) 2
- Dose reduction required in CKD or with CYP3A4/P-glycoprotein inhibitors 1
- More expensive than corticosteroids or NSAIDs 1
Critical Timing Consideration
Treat within 12 hours of symptom onset for optimal response 2. Patient education should include instructions for self-medication with pre-prescribed treatment at first sign of flare.
Management During Active Flare
Can You Start Urate-Lowering Therapy During a Flare?
If ULT is indicated, conditionally recommend starting during the flare rather than waiting for resolution 3. This approach prevents treatment delays without worsening outcomes.
If Patient Already on ULT
Continue ULT without interruption during acute flare 3. Stopping ULT causes serum urate fluctuations that may prolong or worsen the attack.
Common Pitfalls to Avoid
Don't use high-dose colchicine regimens (1.2 mg followed by 0.6 mg hourly for 6 hours)—this causes unnecessary GI toxicity without added benefit 1
Don't assume indomethacin is superior—this is a clinical myth without evidence 1
Don't delay treatment waiting for crystal confirmation—clinical diagnosis is sufficient to initiate therapy 1
Don't stop existing ULT during acute flare—this worsens urate fluctuations
Initiating Long-Term Management
When treating the acute flare, discuss long-term ULT if patient has:
- ≥2 gout attacks per year
- Tophi present
- Chronic kidney disease
- Urolithiasis
- Radiographic gouty arthropathy 1, 4
If initiating ULT, always prescribe concomitant anti-inflammatory prophylaxis for 3-6 months (colchicine, NSAIDs, or low-dose corticosteroids) to prevent flares during ULT initiation 3. This prophylaxis is strongly recommended and reduces flare risk during the critical early treatment period.
ULT Specifics (For Context)
When ULT is indicated: